Protyon Alternatives & Competitors
12 companies similar to Protyon — Guiding clinicians towards personalized treatment and enhancing quality of life...
Companies similar to Protyon
Cvergenx
An innovative leader in cancer molecular diagnostics, delivering personalized radiation th...
Tampa, United States
BioReperia
Accelerating drug discovery and predicting the best cancer treatment for you!
Linkoping, Sweden
BoomRay Pharmaceuticals
成为国际一流、品质卓越的放射性药物公司 Global pioneer in radiopharmaceuticals and commitme...
Suzhou, China
Theramir Ltd
Developing novel microRNA based therapeutics and companion diagnostics for patients and he...
Limassol, Cyprus
Track all Protyon competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Genus Oncology LLC
Discovering New Frontiers in Anti-Cancer Therapeutics: Targeting MUC1 for a Healthier Tomo...
Soricimed Biopharma Inc.
Dedicated to developing effective and novel targeted treatments for cancer.
Canada
Arrogene, Inc.
Innovative cancer treatment technology delivering advanced nano agents to target tumors, e...
PMV Pharmaceuticals, Inc.
Harnessing the power of p53 to treat cancer
Princeton, United States
VitroScan
Predictive Testing Solutions
Leiden, The Netherlands
GILUPI GmbH
Advancing diagnostic procedures for precision medicine
Potsdam, Germany
Viewpoint Molecular Targeting, Inc.
Targeted α-Particle Radiotherapy for Cancer
Coralville, United States
About Protyon
Protyon, founded in 2022 and headquartered in The Netherlands, operates at the intersection of AI, Health Care, and Life Sciences. The company's mission is encapsulated in its slogan: "Guiding clinicians towards personalized treatment and enhancing quality of life for patients." Protyon leverages molecular structures t...
3D Digital Molecular Modeling, Therapeutic Effectiveness Prediction, Knowledge-based Medication Selection, Clinician Education Courses, Life Science Research Support
Clinicians, Hospitals, Oncologists, Cancer Researchers, Medical Professionals
Personalized Medicine, Molecular Analysis, EGFR Mutations, Lung Cancer Therapy, Protein Targeting, Oncology Research, Clinical Collaboration, Molecular Tumor Board, Patient-Centric Care, Cancer Biomarkers, Precision Oncology, Therapeutic Personalization, Mutation Analysis, Oncology Diagnostics
B2B, B2D, SaaS
Subscription, Service Fee, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Protyon and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Protyon on 6 Jul 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 14 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
